Johnson & Johnson Boosts Brave Coalition's Mission for Breast Cancer Survivors
Johnson & Johnson Boosts Brave Coalition's Mission for Breast Cancer Survivors
Johnson & Johnson Boosts Brave Coalition's Mission for Breast Cancer Survivors
The brave Coalition Foundation has received a major donation from Johnson & Johnson. This funding builds on support that began in 2018 and aims to empower women navigating breast reconstruction after cancer. The foundation, established in 2012, focuses on education and access for survivors across the UK.
The brave Coalition Foundation was set up to help breast cancer survivors understand their reconstruction options. Since its launch, it has pushed for better awareness and fewer barriers to care, regardless of insurance or financial status. The group believes every woman should have the right to shape her own recovery journey.
Johnson & Johnson's latest contribution strengthens its long-term commitment to patient-centred reconstruction education. The company has backed the foundation since 2018, emphasising the need for support throughout the healing process.
Lisa Shumpert, the foundation's president, said the donation will expand its reach and deepen its impact. The funds will go towards advocacy, education, and ensuring fair access for survivors nationwide.
The donation will help the foundation continue its work in advocacy and empowerment. It reinforces efforts to give breast cancer survivors more control over their reconstruction choices. The partnership between Johnson & Johnson and the brave Coalition Foundation remains focused on long-term support for women's recovery.